Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Reform Bills Head To Conference; Competitive Bidding Fuels Debate

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed will work closely with Sens. Rick Santorum (R-Penn.) and Blanche Lincoln (D-Ark.) to ensure language easing criteria for new technology "add-on" payments is included in the final Medicare bill

You may also be interested in...



Medicare Technical Corrections Legislation Doubtful After Rx Bill Passage

The resolve of House Republican leaders to avoid re-opening the controversial Medicare law with a technical corrections bill in 2004 will limit DME competitive bidding opponents' options in repealing the provision

Medicare Technical Corrections Legislation Doubtful After Rx Bill Passage

The resolve of House Republican leaders to avoid re-opening the controversial Medicare law with a technical corrections bill in 2004 will limit DME competitive bidding opponents' options in repealing the provision

Device Industry Extols Medicare Passage Despite Competitive Bidding Thorn

AAHomecare plans to meet with CMS officials Dec. 3 to seek clarification on DME competitive bidding provisions in the Medicare reform bill, following whirlwind floor votes and last-minute negotiating

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018630

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel